Reach Us +44-1625-708989
MicroRNA as Upcoming Biomarkers for Psychiatric Conditions | OMICS International | Abstract
ISSN: 2572-0791

Clinical Depression
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

MicroRNA as Upcoming Biomarkers for Psychiatric Conditions

Anoop Narahari*, Mariyah Hussain and Venkatesh Sreeram

University of Alabama, Department of Psychiatry and Behavioral sciences, Birmingham, Alabama, USA

*Corresponding Author:
Narahari A
University of Alabama
Department of Psychiatry and Behavioral sciences
Birmingham, Alabama, USA
E-mail: [email protected]

Received Date: August 31, 2015; Accepted Date: September 02, 2015; Published Date: November 15, 2015

Citation: Narahari A, Hussain M, Sreeram V (2015) MicroRNA as Upcoming Biomarkers for Psychiatric Conditions. Clin Depress 1:103. doi:10.4172/2572-0791.1000103

Copyright: © 2015 Narahari A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Neural derived exosomes can be used as a diagnostic marker to screen various psychiatric conditions. These intravenously injected exosomes carry the potential to cross the blood brain barrier and deliver miRNA specifically to neurons, microglia, and oligodendrocytes in the brain, resulting in a specific gene knockdown. MicroRNAs have been identified as markers in depression where miR-16 has been found to be a negative regulator of the serotonin transporter (SERT) through computer analysis. Futhermore, where miR 134 levels in bipolar disorder have been discovered to be inversely correlated with severity of manic symptoms; manipulating expression or activity of miR-219 can prove as a therapeutic tool for schizophrenia. Despite these studies, the exact nature and extent of dysregulation of microRNAs in psychiatric disorders is yet to be determined. To realize the therapeutic potential of MiRNAs in greater depth; efficient, tissue-specific and nonimmunogenic delivery of exosomes must be developed.


Recommended Conferences

8th World Congress on Depression and Anxiety

Tokyo, Japan
Share This Page